Pharmeasy API Holdings Ltd Shares

Pharmeasy API Holdings Ltd Shares Price

₹7.50M

Checking authentication...

Pharmeasy API Holdings Ltd Shares

Phone

About Share

Pharmeasy API Holdings Ltd Shares

API Holdings Limited, commonly known as PharmEasy, is India's largest digital healthcare platform, primarily involved in the trading of pharmaceutical and cosmetic goods, as well as providing various healthcare services. The company was incorporated on March 31, 2019, and has since evolved into a comprehensive digital healthcare ecosystem.

Fundamentals

NamePharmeasy API Holdings Ltd Shares

Price₹9

Lot Size₹1000.0

52 Week High13

52 Week Low₹8

DepositoryNSDL&CDSL

PAN NumberAASCA1201E

ISIN NumberINE0DJ201029

CINU60100MH2019PLC323444

RTA-

Market Cap (in cr)541114

P/E Ratio-₹96.6

P/B Ratio1.14

Debt to Equity-

ROE (%)-

Book Value7.7

Face Value₹1.0

Valuation-

Total Shares6142041070

Financial (In Cr)

Shareholding Pattern

Promoters

FAQ's

Our Blogs

Our blog provides insightful information about unlisted shares, offering a deeper understanding of how these assets work, their potential benefits, and the risks involved. Whether you're new to unlisted shares or looking to expand your knowledge, we cover topics such as investment strategies, valuation methods, market trends, and regulatory aspects. Stay updated with expert tips and guides to navigate the unlisted share market effectively.

OYO Unlisted Share Price: Latest Trends & Insights

Explore the latest OYO unlisted share price trends and valuation insights. Stay informed to make smart investment decisions today.

Bootes Impex Tech Ltd: Pre-IPO Analysis, and Strategic Implications

Bootes Impex Tech Ltd is preparing for an IPO, aiming to raise ₹1,000–1,500 crore to expand sustainable infrastructure and R&D. While the IPO presents strong growth potential, risks around execution, valuation, and market dynamics must be carefully managed.

Bootes Impex Tech Ltd Investment Guide: Opportunities and Risks

Bootes Impex Tech Ltd offers a compelling investment opportunity in the net-zero construction sector, backed by proprietary technologies, a strong order book, and alignment with India's sustainability vision. However, investors must consider risks like liquidity constraints, execution challenges, and regulatory uncertainties due to its unlisted status and industry complexities.